$VSCONeutralMed

Australian billionaire Brett Blundy wages high-stakes campaign to oust chair of Victoria’s Secret

Australian billionaire Brett Blundy’s BBRC International, which holds about 13% of Victoria’s Secret & Co, is seeking to remove long-term chair Donna James at the company’s US annual meeting Thursday. BBRC says shareholders have faced value destruction and governance issues. Victoria’s Secret and proxy firms ISS, Glass Lewis and Egan-Jones back the board, citing improved performance; shares are up over 50% in the past month.

7/10
6/10
Med
Neutral
Ahead of Victoria’s Secret annual meeting vote (Thursday 8:30am ET).
Mixed: shares up >50% past month, but governance/board-change risk remains.

Proxy fight and poison-pill mechanics raise near-term event risk around board control and takeover optionality.

BBRC, holding ~13% of Victoria’s Secret, is campaigning to remove chair Donna James ahead of the US annual meeting and potential hostile takeover.

Elevated volatility into the annual meeting; direction depends on proxy advisory support vs dissident momentum.

Background

BBRC International (Blundy’s firm) has been seeking board influence since ~2021; the dispute escalated publicly in May with a request to remove the chair and another director.

Why it matters

A successful vote could change board oversight and increase takeover/strategic review probability; failure likely reinforces current strategy and reduces near-term takeover odds.

Market relevance

Traders should treat this as an event-driven governance catalyst with potential volatility into the annual meeting, tempered by recent share strength and proxy advisory support.

Market effects

Highlights governance and takeover-defense dynamics in consumer/retail brands; could affect sentiment toward other takeover targets with poison pills.

Primarily US-listed consumer retail; potential spillover to proxy-advisory-driven governance trades.

Limited beyond cross-border investor activism narrative (Australian billionaire via BBRC).

Alternative perspectives

Strong recent stock performance and proxy-advisory support may blunt the dissident’s ability to unseat the chair despite governance criticisms.

Poison pill dilution mechanics and the dissident’s ability to convert support into votes are likely more decisive than the reputational/strategy arguments.

Key entities

  • Victoria’s Secret & Co

    US-listed lingerie/beauty company facing a dissident campaign to remove its long-term chair.

  • BBRC International

    Blundy’s investment firm owning ~13% and leading the campaign for board changes.

  • Donna James

    Long-term chair targeted for removal at the annual meeting.

  • Institutional Shareholder Services (ISS)

    Advised against voting out the chair while acknowledging some concerns.

Related articles

$GOOGMedAI 8/10

Dow Jones regains ground despite worries of valuation bubble, Nasdaq 'supported by FOMO'

US stocks held near record highs as investors weighed Middle East tensions and valuation concerns, with IG’s Axel Rudolph saying Friday’s US non-farm payrolls will guide Fed expectations. April job openings rose by nearly 730,000 to 7.618 million. Alphabet plans an $80B stock sale for AI capex. Several companies reported results and guidance, including HPE and Signet.

$GNRCMedAI 9/10

Stocks making the biggest moves midday: Coherent, Victoria's Secret, Marvell, HPE, Generac, Intuit & more

Midday movers: Generac rose ~6% on a deal to supply backup power for a hyperscale data center operator. Intuit fell ~9% after Goldman Sachs downgraded to sell, citing ~22% downside. Shake Shack dropped 10% after cutting full-year earnings and Q2 revenue guidance. HPE jumped ~16% on stronger AI server demand and raised guidance. Victoria’s Secret gained ~44% after raising FY sales guidance to $7.03–$7.13B.

$MRVLHighAI 9/10

Stocks making the biggest moves premarket: Marvell Technology, Hewlett Packard Enterprise, Victoria's Secret & more

Premarket movers: Marvell shares rose 25% after Nvidia CEO Jensen Huang said it could become a next “trillion-dollar” company. Hewlett Packard Enterprise gained 25% after topping current-quarter earnings/revenue guidance, raising full-year guidance. Victoria’s Secret jumped 35% after raising full-year sales guidance to $7.03–$7.13B. Credo fell 3% despite a Q4 beat (EPS $1.16 on $437M revenue, per LSEG). Microchip rose 12% on data center unit revenue of $302.7M in 2025 and ~65% growth outlook. Al

$GOOGMedAI 8/10

Stock market today: Dow, S&P 500, Nasdaq futures slip as US-Iran tensions weigh on AI optimism

US stock futures slipped from record highs as investors weighed US-Iran tensions alongside AI optimism. Dow futures fell 0.4%, S&P 500 futures about 0.2%, Nasdaq 100 near flat. Alphabet said it plans to raise $80B for AI infrastructure; HPE reported a record AI-driven quarter, up over 20%. Brent fell 1% to $93 and WTI to $91. JOLTS and several earnings are due Tuesday.

$GOOGMed

Dow, S&P 500, Nasdaq futures dip ahead of key jobs data

US stock futures fell ahead of US jobs data as investors weighed uncertainty around Iran talks and ongoing AI developments, according to Yahoo Finance. Dow and S&P 500 futures slipped 0.2%, Nasdaq 100 futures fell 0.3%. Alphabet said it plans to raise $80B for AI infrastructure; HPE reported a record AI-driven quarter. Investors look to Tuesday’s JOLTS and May jobs data Friday.